Studying Tumor-ReacTive T Cells: A Personalized Organoid Model.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 30193129.
- Also identified by DOI 10.1016/j.stem.2018.08.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recently in Cell, Dijkstra et al. (2018) introduced a tumor organoid/lymphocyte co-culture-based approach to expand and analyze tumor-specific T cell responses in a patient-specific manner. The platform is applicable for epithelial cancers and may have significant value for clinical translation of novel personalized immunotherapies.
Medical subject headings
- Neoplasms
- Organoids